Plasma activin A rises with declining kidney function and is independently associated with mortality in patients with chronic kidney disease.

P-activin A increased with declining kidney function and was associated with all-cause mortality independently of age, sex, DM and eGFR. No association with MACE, vascular calcification or BMD was demonstrated.